You are here

Generic Equivalent of Zovirax Suspension Garners Approval

AMITYVILLE, N.Y.--(BUSINESS WIRE)--June 9, 2005--Hi-Tech Pharmacal Co., Inc. announced that the US Food and Drug Administration (FDA) has granted an approval to the Company's Abbreviated New Drug Application (ANDA) for Acyclovir Oral Suspension, USP 200 mg/5mL.

Hi-Tech's Acyclovir Oral Suspension, USP 200 mg/5mL is the generic equivalent of GlaxoSmithKline's Zovirax Suspension indicated for the treatment of herpes zoster infections, genital herpes and chicken pox. The Company expects to start marketing its Acyclovir Oral Suspension, USP 200 mg/5 mL in June, 2005.

Source: Hi-Tech Pharmacal Co.

Recent Headlines

Scenesse is new treatment for people with rare, painful light sensitivity disease
Humira, Rituxan top list of drugs that added $5.1 billion to nation's health care bill
Lower court rulings cleared the way for generic versions of the MS drug
Maryland man wins lawsuit that alleges that the company's antipsychotic caused his gynecomastia
Antidepressants, ADHD meds are also used to self-poison
U.S. maintains measles elimination status as NY outbreak ebbs
Study lists steps that could save close to $300 billion a year
While many victims used THC, the cause remains elusive
Descovy joins Truvada, another Gilead product, in the HIV prophylaxis market